Syd Labs 人IgG4-S228P同型对照抗体引用文献

Syd Labs 人IgG4(S228P)同型对照抗体引用文献如下：

1. Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders
Stephanie Maciuba,et al.MAbs. 2023.PMCID: PMC10498814
“FcγR binding of PRL mAbs or human IgG1 (Syd Labs Inc., #PA007125), IgG2 (Syd Labs Inc., #PA007127), and IgG4(S228P) (Syd Labs Inc., #PA007128) isotype controls were estimated using NanoBiT FcγR binding immunoassays (Promega) as described previously.”
2. Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson,et al.J Immunother Cancer. 2024.PMCID: PMC11284835
“Human isotypes IgG1 and IgG4 were generated by Syd Labs (Natick, Massachusetts, USA) and are referred to as Medi-1 and Medi-4, respectively. ”
3. DEspRhigh neutrophils are associated with critical illness in COVID-19
Joanne T. deKay,et al.Sci Rep. 2021.PMCID: PMC8599677
“Human IgG4-S228P isotype control was obtained from Syd Labs (Southborough, MA).”
……

Syd Labs 重组人IgG4-S228P同型对照抗体，体内实验级（货号：PA007128）：

Syd Labs 体内实验级重组人IgG4-S228P同型对照抗体（In Vivo Grade Recombinant Human IgG4-S228P Isotype Control Antibody，货号：PA007128）是用CHO细胞生产的重组抗体，人源化可变区和人IgG4 kappa不变区，可用于ELISA、Western Blot、流式细胞术、免疫沉淀、免疫组织化学和体内动物模型研究的人IgG4 kappa抗体的同型匹配阴性对照。

Syd Labs 强烈呼吁珍爱生命、减少使用动物生产抗体!

关于Syd Labs 重组抗体如果有任何技术或其它问题，以及申请Syd Labs中国代理商授权、确认代理商真伪或者举报代理商，欢迎随时联系：企业微信：duozhaozhao2024 联系电话：18162581039（龙经理）。